ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ESMO 2023
17:34

ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-671

FEATURING Luis Raez
  • 909 views
  • February 23, 2024
  • 5
07:29

ecancer

ESMO 2023 Insights: "BEATcc Trial - 1L Chemo With Atezolizumab & Bevacizumab for Metastatic Persistent or Recurrent Cervical Cancer"

FEATURING Ana Oaknin
  • 98 views
  • December 11, 2023
03:02

ecancer

ESMO 2023 Insights: "WSG-ADAPT Trial - Multiparametric Prognostic Score in Early HR+/HER2- BC"

FEATURING Oleg Gluz
  • 79 views
  • December 7, 2023
  • 1
08:15

ecancer

ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"

FEATURING Bishal Gyawali
  • 404 views
  • November 15, 2023
  • 7
02:36

ecancer

ESMO 2023 Summary: "Highlights From Recent Prostate and Bladder Cancer Trials"

FEATURING Bishal Gyawali
  • 94 views
  • November 15, 2023
03:31

ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials"

FEATURING Bishal Gyawali
  • 310 views
  • November 15, 2023
  • 2
07:32

ecancer

ESMO 2023 Summary: "CAR-T Therapy & Impact to Cancer Patient Outcomes and Experience of Treatment"

FEATURING Matthias Hellberg-Naegele
  • 16 views
  • November 15, 2023
02:49

ecancer

ESMO 2023 Insights: "Alliance A021602 Study - Cabozantinib vs. Placebo for Advanced Neuroendocrine Tumours After Progression on Prior Therapy"

FEATURING Jennifer Chan
  • 160 views
  • November 14, 2023
02:21

ecancer

ESMO 2023 Insights: "SWOG S1801 Study - Resectable Melanoma Treated With Neoadjuvant/Adjuvant Pembro"

FEATURING Sapna Patel
  • 37 views
  • November 13, 2023
02:47

ecancer

ESMO 2023 Insights: "Tisotumab Vedotin vs. Investigator’s Choice of Chemo in 2L/3L Recurrent/Metastatic Cervical Cancer"

FEATURING Ignace Vergote
  • 76 views
  • November 13, 2023
  • 1
02:38

ecancer

ESMO 2023 Insights: "Pembro + CRT For High-Risk Locally Advanced Cervical Cancer"

FEATURING Domenica Lorusso
  • 100 views
  • November 13, 2023
  • 1
03:31

ecancer

ESMO 2023 Insights: "Benefit of Adjuvant RT Following Radical Prostatectomy for Prostate Cancer Patients"

FEATURING Noel Clarke
  • 151 views
  • November 3, 2023
  • 2
03:00

ecancer

ESMO 2023 Insights: "Feasibility & Safety of Boost at 74 Gy Based on Interim FDG-PET During Thoracic Radio-Chemotherapy for NSCLC Patients"

FEATURING Gerard Zalcman
  • 43 views
  • November 3, 2023
02:41

ecancer

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in Patients With Resectable CSCC"

FEATURING Neil Gross
  • 104 views
  • November 3, 2023
03:53

ecancer

ESMO 2023 Insights: "ANITA Trial on Atezolizumab With Platinum-Based Chemotherapy and Maintenance Niraparib for Recurrent Ovarian Cancer"

FEATURING Antonio González-Martín
  • 81 views
  • November 3, 2023
01:59

ecancer

ESMO 2023 Insights: "Phase 3 GCIG INTERLACE Trial - Induction Chemotherapy Followed by Chemoradiation Compared With Chemoradiation Alone in Locally Advanced Cervical Cancer"

FEATURING Mary McCormack
  • 110 views
  • October 30, 2023
19:46

ecancer

ESMO 2023 Summary: "PARPi Combinations to Treat Patients With mCRPC - MAGNITUDE, TALAPRO-2 and PROpel Trials"

FEATURING Axel Merseburger, Karim Fizazi, Laura-Maria Krabbe, Gerhardt Attard
  • 154 views
  • October 30, 2023
03:11

ecancer

ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib & Panitumumab in KRAS G12Cm mCRC"

FEATURING Filippo Pietrantonio
  • 266 views
  • October 27, 2023
  • 1
06:42

ecancer

ESMO 2023 Insights: "LIBRETTO-431 Phase 3 Study of 1L Selpercatinib vs. Chemo & Pembro in RET Fusion+ NSCLC"

FEATURING Herbert Loong
  • 278 views
  • October 27, 2023
  • 2
03:36

ecancer

ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotamab Deruxtecan Compared to Chemo in Patients With Advanced HR+/HER2- BC"

FEATURING Aditya Bardia
  • 597 views
  • October 27, 2023
  • 5
02:05

ecancer

ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Placebo in Combination With Neoadjuvant Chemo Followed by Adjuvant ET in Patients With High-Risk ER+ HER2- BC"

FEATURING Sherene Loi
  • 468 views
  • October 25, 2023
  • 5
05:21

ecancer

ESMO 2023 Insights: "Effects of Short-Term Fasting on Quality of Life as an Add-On Option During Chemo"

FEATURING Daniela Koppold-Liebscher
  • 122 views
  • October 25, 2023
13:29

ecancer

ESMO 2023 Insights: "Genomic Testing - Awareness & Effective Communication Between Healthcare Professionals and Patients"

FEATURING Richard Simcock, Antonella Cardone
  • 107 views
  • October 25, 2023
  • 1
04:57

ecancer

ESMO 2023 Insights: "Phase 3 LIBRETTO-531 Study - Selpercatinib for Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer"

FEATURING Julien Hadoux
  • 47 views
  • October 25, 2023
04:31

ecancer

ESMO 2023 Insights: "Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial - Combination of Durvalumab With Standard 1L Chemo +/- Olaparib in Patients With Advanced Endometrial Cancer"

FEATURING Shannon Westin
  • 179 views
  • October 25, 2023
  • 1
02:07

ecancer

ESMO 2023 Insights: "CheckMate 901 Trial - Nivo+Gem-Cis vs. Gem-Cis Alone for Previously Untreated Unresectable/Metastatic Urothelial Carcinoma"

FEATURING Michiel Van Der Heijden
  • 118 views
  • October 25, 2023
  • 1
22:00

ecancer

ESMO 2023 Insights: "A Biomarker-Led Approach to Bladder Cancer"

FEATURING Andrea Necchi, Guillermo De Velasco, Arlene Siefker-Radtke, Yohann Loriot
  • 119 views
  • October 25, 2023
19:02

ecancer

ESMO 2023 Insights: "Latest in EGFR Ex20ins Advanced NSCLC"

FEATURING Alex Spira, Joshua Sabari, Enriqueta Felip
  • 195 views
  • October 25, 2023
25:48

ecancer

ESMO 2023 Insights: "The Latest in NSCLC With Common EGFR Mutations"

FEATURING Alfredo Addeo, Antonio Passaro, Alex Spira, Amanda Tufman
  • 314 views
  • October 25, 2023
  • 2
14:05

ecancer

ESMO 2023 Insights: "Phase 3 CheckMate-77T Study - Perioperative Nivo + Chemo for Resectable NSCLC"

FEATURING Tina Cascone
  • 304 views
  • October 25, 2023
  • 6
02:35

ecancer

ESMO 2023 Insights: "Phase 2 KRYSTAL-7 Trial - Adagrasib+Pembro Combo for KRASG12C+, Treatment-Naïve, Advanced NSCLC"

FEATURING Pasi Janne
  • 98 views
  • October 25, 2023
06:01

ecancer

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Combination of EV & Pembro Compared to Chemo for 1L Advanced Urothelial Cancer"

FEATURING Thomas Powles
  • 508 views
  • October 25, 2023
  • 3
01:53

ecancer

ESMO 2023 Insights: "Results From Phase 2 LITESPARK-003 Study - Belzutifan+Cabozantinib Combination for Advanced ccRCC"

FEATURING Toni Choueiri
  • 78 views
  • October 25, 2023
02:23

ecancer

ESMO 2023 Insights: "Comparing Belzutifan With Everolimus in Pretreated Advanced Clear Cell RCC - Results From LITESPARK-005 Study"

FEATURING Toni Choueiri
  • 70 views
  • October 25, 2023